Fresenius reported €15.35B in Current Liabilities for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Akzo Nobel AKZA:NA € 4407M 557M
Alcon AG ALC:SW 2.38B 172M
AstraZeneca AZN:LN 23649M 1427M
BASF BAS:GR € 20322M 788M
Bayer BAYN:GR € 28727M 801M
Davita Healthcare Partners DVA:US $ 2363.05M 22.99M
DSM DSM:NA € 2264M 82M
E.ON EOAN:GR 34.17B 11.19B
Fresenius FRE:GR € 15352M 148M
Fresenius Medical Care FME:GR € 7492M 67.37M
Fresenius Medical Care FMS:US $ 7492M 67.37M
Getinge GETIB:SS SK 7373M 157M
Givaudan GIVN:VX 2.41B 618M
GlaxoSmithKline GSK:LN 22417M 1030M
GN Store Nord GN:DC DK 4969M 394M
GRIFOLS GRF:SM € 1921.48M 360.62M
Hikma Pharmaceutical HIK:LN 960M 68M
Lonza Group LONN:SW 3.11B 12M
Merck MRK:GR € 9793M 27M
Novartis NOVN:VX SF 29880M 247M
RWE RWE:GR € 103136M 65407M
William Demant Holding WDH:DC 9.47B 2.1B